Grace Therapeutics, Inc. (GRCE)
Operating Cash Flow (Statement)
-$10.30M
TTM · Period ending: · USD
GRCE Operating Cash Flow (Statement)
Latest reported-$10.30Mperiod ending
Latest reported-$10.30Mperiod ending
GRCE Cash from Operations (-$157.52K → -$10.30M)
Annual operating cash flow (statement)
High-resolution chart · PNG
GRCE operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -8,869,000 | |
| -14,904,000 | |
| -12,333,000 | |
| -15,913,000 | |
| -17,234,000 | |
| -17,988,196 | |
| -32,442,959 | |
| -24,787,000 | |
| -9,694,055 | |
| -6,941,119 | |
| -4,851,266 | |
| -5,753,015 | |
| -6,115,558 | |
| -2,489,760 | |
| -5,647,507 | |
| -1,914,490 | |
| -1,901,986 | |
| -157,518 |